Streetview Daily Updates
Top Gainers
Top Losers
Trending Now
S&P 500 : IPO Frenzy Fizzles as top 10 debuts disappoint investors in 2025.
Novo Nordisk : Novo Nordisk partners with Emcure to distribute weight loss drug semaglutide in India.
Torrent Pharmaceuticals : Torrent Pharmaceuticals shares jump up to 9% after Q2 results.
Get daily predictions and stock updates
Intraday Momentum Scanner: Stocks Breaking Out Right Now
P/E Ratio
The Price-to-Earnings (P/E) Ratio is a key financial metric used to evaluate a company's valuation.It is calculated by dividing the current share price by the earnings per share (EPS).
A high P/E ratio may indicate that a stock is overvalued or that investors are expecting high growth rates in the future, while a low P/E ratio might suggest that the stock is undervalued or that the company is experiencing difficulties.
Investors often use the P/E ratio to compare companies within the same industry or to assess market trends over time.
Relation to Current Market Conditions:
As of now, the P/E ratios of many tech stocks have come under scrutiny due to rising interest rates and inflation concerns.Investors are increasingly cautious, as high P/E ratios may not be sustainable in a tightening monetary environment.
Recent market volatility has led to a reevaluation of growth stocks, with many analysts suggesting that a more conservative approach to valuation is warranted
Volatility Alert: Stocks With Highest Implied Volatility Today
IPO Insights
Daily Stock Market News
Nov 10
Emkay Global Financial recommends reducing Britannia Industries with a target price of Rs 5750.
Nov 10
Emkay Global Financial recommends reducing Firstsource Solutions with a target price of Rs 350.
Nov 10
Emkay Global Financial recommends buying Route Mobile with a target price of Rs 1000.
Nov 10
Emkay Global Financial recommends buying One 97 Communications with a target price of Rs 1600.
Nov 10
Emkay Global Financial recommends buying State Bank of India with a target price of Rs 1100.
Nov 10
Emkay Global Financial recommends buying Sun Pharma with a target price of Rs 2000.
New to trading? Our hand-holding support makes getting started easy!
Join Streetgains Today! Pay for Successful Research Calls - Credit Based Subscription.
Get Started Now
Market Spotlight
Neha Nankani • February 26, 2025
Next Multibagger Stock: How to Identify Potential Winners Before They SoarThe dream of every investor is to find that one stock...
Neha Nankani • February 26, 2025
How to Spot High Growth Multibagger Penny Stocks?Investors always look for opportunities that can turn small investments ...
Neha Nankani • February 26, 2025
EPS Formula: How to Calculate Earnings Per Share?Earnings Per Share (EPS) is a crucial financial metric that helps investors...
Neha Nankani • February 26, 2025
What is the PE Ratio in the Share Market? Meaning, Calculation & ImportanceThe Price-to-Earnings (PE) ratio is a crucial valuation metric...
Are You Frustrated With Unregistered Research Firms and Costly, Unsuccessful Trade Recommendations?
Subscribe to our Credits-Based Research System: Pay only for successful research calls!
No more locked-in contracts or high fees for poor performance.
Pay only for successful research calls!
